SCHEMBL1389910

SCHEMBL1389910

COC(=O)c1ccc(-c2ccc(C(C/C(=N\O)c3ccc(=O)n(C)c3)c3ccccc3C)c(F)c2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 3/20 0.40
CTSA P10619 10/20 0.35
FFAR1 O14842 1/20 0.35
PKM P14618 1/20 0.35
NR4A2 P43354 1/20 0.34
PDGFRB P09619 2/20 0.32
FGFR1 P11362 2/20 0.32
PDGFRA P16234 2/20 0.32
FLT1 P17948 2/20 0.32
FGFR3 P22607 2/20 0.32
KDR P35968 2/20 0.32
NPC1 O15118 1/20 0.32
MME P08473 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389912 1.00 GPBAR1 (0.40) GPBAR1CTSAFFAR1PKMNR4A2
SCHEMBL1390112 0.92 GPBAR1 (0.44) GPBAR1CTSAFFAR1PKMCYP3A4
SCHEMBL1390114 0.92 GPBAR1 (0.44) GPBAR1CTSAFFAR1PKMCYP3A4
SCHEMBL1390206 0.88 GPBAR1 (0.51) GPBAR1CTSAFFAR1CYP3A4
SCHEMBL1390207 0.88 GPBAR1 (0.51) GPBAR1CTSAFFAR1CYP3A4
SCHEMBL15949108 0.88 GPBAR1 (0.40) GPBAR1CTSAFFAR1MMECYP3A4
SCHEMBL368681 0.88 BDKRB1 (0.41) GPBAR1
SCHEMBL15949026 0.86 GPBAR1 (0.41) GPBAR1CTSAFFAR1
SCHEMBL15949230 0.86 GPBAR1 (0.42) GPBAR1CTSAFFAR1CYP3A4
SCHEMBL1390087 0.86 GPBAR1 (0.43) GPBAR1CTSAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885CTSA 3225/4885FFAR1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.